Cynthia Matossian, MD, FACS published the article "Toric IOL Properties" in the January 2014 issue of EyeWorld. To view this article click
All MEA's Optometrists attended the meeting of the New Jersey Society of Optometric Physicians in Princeton, NJ for continuing education in March 2014.
Cynthia Matossian, MD, FACS participated as a panelist in MARCO's 'Power Forum 2' event.
Ilya Rozenbaum, MD attended the annual meeting of the American Glaucoma Society in Washington, DC.
Cynthia Matossian, MD, FACS participated as faculty at the Hawaiian Eye Meeting on January 18-24, 2014 to discuss Toric IOLs.
Ilya Rozenbaum, MD presented an educational lecture on glaucoma to the surgeons at the Surgery Center of Central New Jersey.
Cynthia Matossian, MD, FACS led several live webinars and round table discussions for Ophthalmologists, Optometrists, and other eye care professionals across the country.
Priya Desai, MD presented an educational lecture on New Treatment Options for Cataracts to the Bucks County community on March 2014.
Cynthia Matossian, MD, FACS presented a variety of lectures on ophthalmic products, medications and/or surgical techniques throughout the United States to many groups of ophthalmologists.
| || |
Cynthia Matossian, MD Invited to Join OSN Editorial Board
As a key opinion leader in the ophthalmic community, Cynthia Matossian, MD, FACS has been invited to join the Ocular Surgery News (OSN) editorial board. Dr. Matossian accepted this invitation on Monday, March 17, 2014. The term for an editorial board member is five years.
During her tenure she will:
- Occasionally be asked to be available for interviews conducted by staff writers.
- Be asked to offer insight and suggestions to improve editorial content and focus.
- Be asked to contribute articles for publication that would be of interest to the ophthalmic community.
- Be asked to attend a yearly editorial board meeting held at the American Academy of Ophthalmology meeting.
Matossian Eye Associates congratulates Dr. Matossian on her election to this prestigious position!
Dr. Matossian Joins the Board of ACES
Cynthia Matossian, MD, FACS was recently invited to join the board of the American College of Eye Surgeons (ACES). This organization is committed to promoting, encouraging, and enhancing quality ophthalmic surgical care for the benefit of all patients.
Sjögren's Syndrome Detection
Matossian Eye Associates has begun implementing the new test for Sjorgen's Syndrome mentioned in our last issue. Sjö™ is a proprietary laboratory test developed by Immco Diagnostics, Inc. and distributed by Nicox which combines traditional markers with three novel, proprietary biomarkers, allowing earlier detection of the disease.
To facilitate the implementation of the Sjö™ test, the doctors of MEA are holding intimate dinner functions and roundtable discussions with local physicians in the fields of internal medicine, family practice, and rheumatology who are interested in learning more about the Sjö™ test. If you are interested in attending one of these upcoming dinner discussions, please contact our administrative assistant at
(609) 323-1560, opt. 4.
Dr. Matossian is a V-Blogger!
Cynthia Matossian, MD, FACS, in partnership with Ocular Surgery News, has begun publishing brief video blogs on the topic of Bridging the Reimbursement Gap in Medical Practices. They feature products and services that she has found to create additional sources of revenue while helping patients. These V-Blogs are published on the website of Ocular Surgery News.
You can view them here.
Please click on the video below for an introduction to the series.
Cynthia Matossian, MD discusses OPD III on MARCO Power Forum II. To view the video, click here
or select the icon below:
|Cynthia Matossian, MD, FACS speaks at MARCO Power Forum 2 Discussion|
Dr. Matossian Named An Outstanding Female Ophthalmic Leader
MillenialEye, an all digital, app-based publication and online community targeting the future leaders in ophthalmology, recently named Cynthia Matossian, MD, FACS an Outstanding Female Ophthalmic Leader and an inspiration behind their Outstanding Female in Ophthalmology Award program.
| | MEA Now Offers Allergy Testing
MEA has started to offer Allergy Matrix pinpoint allergy testing for patients who suffer from ocular allergies. Some of the key advantages of the Allergy Matrix include:
- Results in 10-15 minutes.
- The ability to diagnose and treat patients with allergy symptoms to increase the level of care.
- Custom antigens reflecting the Northeast allergy profile.
A video on this new test can be viewed here
Dr. Matossian Joins ACOS
The American-European Congress of Ophthalmic Surgery (ACOS), a prestigious society dedicated to advancing vision care and improving patients' quality of life through innovation, education, and advocacy has invited Cynthia Matossian, MD, FACS to become a member.
MEA is Active in a Variety of Clinical Studies
- Tear Osmolarity on Pre-Surgical Calculations in Cataract Surgery. This study is closed. We met our enrollment goal.
- Rapid Pathogen Screening Adeno Virus. We are looking for 'red eyes' to enroll in this study.
- The Influence of the PRN Dry Eye Omega 3 Nutritional Regimen in Osmolarity. We are about to start this study.
- Restasis Induction Study: Enrollment is closed; this study is in the data analysis phase.
- Intra-op Injection to Decrease Inflammation in Cataract Surgery Patients. We are actively enrolling patients into this study.
- Hoffer H5 IOL Formula. This study is in the data collection phase where gender and race are factored in IOL power calculations formulas.
Matossian Eye Associates is Proud to Welcome Mark Moster, MD to Our Practice
MEA is proud to welcome Mark L. Moster, MD - a world-reknowned neuro-ophthalmologist from Will's Eye in Philadelphia, Pennsylvania.
Dr. Moster will be seeing patients in our Hopewell, New Jersey office one morning a month.
Matossian Eye Associates
was founded in 1987. Our professional objective is to provide every patient with excellent eye care in a personalized and caring manner.
Our practice offers a complete range of preventive and corrective eye care and surgery, using the most advanced technology available for detection and treatment of eye disease.